Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1998Annals of Internal Medicine

Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes Mellitus

View Full Paper
Ask AI
Bookmark
Share

Authors

DMDavid MaggsMetcalf Foundation

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

David Maggs (1998) studied this question.

synapsesocial.com/papers/6a810e1a0914b5fb8de3d459https://doi.org/10.7326/0003-4819-128-3-199802010-00002
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.1987 · 337 citations
  2. 2Effects of Troglitazone: A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy1996 · 180 citations
  3. 3Mechanism of free fatty acid-induced insulin resistance in humans.1996 · 1,546 citations
  4. 4Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.1984 · 405 citations